|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 39/00 | (2006.01) |
| C07K 16/24 | (2006.01) | ||
| A61P 37/06 | (2006.01) | ||
| A61P 35/00 | (2006.01) |
| (11) | Patento numeris | 3328887 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 17840546.0 |
| Europos patento paraiškos padavimo data | 2017-09-18 | |
| (97) | Europos patento paraiškos paskelbimo data | 2018-06-06 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2021-08-18 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/CN2017/102057 |
| Data | 2017-09-18 |
| (87) | Numeris | WO 2018/050111 |
| Data | 2018-03-22 |
| (30) | Numeris | Data | Šalis |
| 201610831525 | 2016-09-19 | CN | |
| 201610832677 | 2016-09-19 | CN |
| (72) |
WANG, Zhengyi , CN
FANG, Lei , CN
GUO, Bingshi , CN
ZANG, Jingwu , CN
|
| (73) |
I-Mab Biopharma (Hangzhou) Co., Ltd. ,
6F, No.3 Bld., Hexiang Technology Center, Qiantang New Area
Hangzhou
Zhejiang,
CN
|
| (54) | ANTI-GM-CSF ANTIBODIES AND USES THEREOF |
| ANTI-GM-CSF ANTIBODIES AND USES THEREOF |